Overview

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of tiragolumab with atezolizumab and bevacizumab in previously-treated advanced non-squamous NSCLC.
Phase:
Phase 2
Details
Lead Sponsor:
Georgetown University
Collaborator:
Genentech, Inc.
Treatments:
Atezolizumab
Bevacizumab